ASND
Ascendis Pharma A/S · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -14.3% ·
aandelenstroom -12.6% ·
netto nieuwe posities -16.7%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | +15 | 28.56M | $7.62B | +25 | −10 |
| Q1 2026 | 92 | -6 | 28.38M | $6.48B | +8 | −14 |
| Q4 2025 | 96 | -1 | 34.58M | $7.37B | — | −1 |
| Q3 2025 | 15 | 0 | 10.69M | $2.13B | +1 | −1 |
| Q2 2025 | 12 | -2 | 9.16M | $1.58B | — | −2 |
| Q1 2025 | 12 | +1 | 5.48M | $853.40M | +1 | — |
| Q4 2024 | 11 | -2 | 5.30M | $729.95M | — | −2 |
| Q3 2024 | 12 | +1 | 6.24M | $930.97M | +2 | −1 |
| Q2 2024 | 11 | — | 7.02M | $958.03M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 4.53M | — | $782.18M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 1.88M | -16.9% | $323.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Wellington Management ✦ | 918.10K | +56.2% | $158.46M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 587.34K | -47.8% | $101.38M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 587.34K | -47.8% | $101.38M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (passief) | 471.73K | — | $81.42M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 459.61K | +40.4% | $79.33M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 29 | Marshall Wace ✦ | 117.16K | +425.5% | $20.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Marshall Wace ✦ | 117.16K | +425.5% | $20.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Marshall Wace ✦ | 117.16K | +425.5% | $20.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Millennium Management ✦ | 72.89K | -72.5% | $12.58M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Geode Capital Management ✦ (passief) | 60.80K | +5.1% | $10.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | State Street Global Advisors ✦ (passief) | 58.20K | -12.8% | $10.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | D. E. Shaw & Co. ✦ | 7.19K | -65.0% | $1.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 3.12K | -83.4% | $537,649 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $88.71M | was 0.3% |
| Duquesne Family Office | $24.74M | was 0.8% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 8 houders, 7.94M aandelen, $34.76M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 1.10K aand @ 245.85 · $270,435
Director · 900 aand @ 246.91 · $222,219
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie